AURA
Aura Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.44
−2.28%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.37
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.48
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.38 | -$0.48 | Miss -28.00% | — |
| May 11, 2026 | -$0.40 | -$0.50 | Miss -25.00% | — |
| Mar 30, 2026 | -$0.43 | -$0.37 | Beat 13.95% | — |
| Nov 13, 2025 | -$0.46 | -$0.40 | Beat 13.04% | — |
| Aug 13, 2025 | -$0.49 | -$0.47 | Beat 4.08% | — |
| May 15, 2025 | -$0.47 | -$0.55 | Miss -17.02% | — |
| Mar 24, 2025 | -$0.43 | -$0.52 | Miss -20.93% | — |
| May 9, 2024 | -$0.51 | -$0.40 | Beat 21.57% | — |
| Nov 9, 2023 | -$0.54 | -$0.48 | Beat 11.11% | — |
| May 11, 2023 | -$0.52 | -$0.46 | Beat 11.54% | — |
| Mar 15, 2023 | -$0.58 | -$0.52 | Beat 10.34% | — |
| Nov 10, 2022 | -$0.52 | -$0.53 | Miss -1.92% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026